Feb 20, 2015 ... application/pdf icon FTC v. Boehringer Ingelheim Pharmaceuticals, Inc. (D.C. Cir.
), Response of FTC to Petition for Rehearing En Banc (113.12 ...
www.leagle.com/decision/1995235234Conn1_1235/TOROSYAN v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
ANUSHAVAN G. TOROSYAN v. BOEHRINGER INGELHEIM
PHARMACEUTICALS, INC. PETERS, C. J. The principal issue in this appeal is
whether there was ...
Feb 20, 2015 ... Pharmaceuticals, Inc. (“Boehringer”), a brand-name pharmaceutical ... See
Boehringer Ingelheim Int'l GmbH v. Barr. Labs. Inc., Civ. Action No. .... omitted);
accord 8 CHARLES ALAN WRIGHT ET AL., FEDERAL. PRACTICE ...
COOK v. CAMDEN COUNTY DEPARTMENT OF CORRECTIONS et al ....
COLEMAN v. ..... BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v.
... patients from the general population at low vs. high risk of early (30 day)
mortality. Font et al. applied similar risk stratification criteria in a population
restricted to ... Disclosures: Coleman: Janssen Pharmaceuticals: Consultancy,
Research ... AG: Consultancy, Research Funding; Boehringer-Ingelheim
Dec 10, 2016 ... 32.7%) and lower total hospital costs (-$240) vs. parenteral bridging to warfarin (
p²0.03 for all) ... Coleman: Boehringer-Ingelheim Pharmaceuticals, inc. ...
Christine Blank, Contributing Editor et al., Formulary Watch , 2016.
Boehringer Ingelheim International GmbH has agreed to pay roughly $650
million to settle claims in multidistrict ... Richard W Cohen, Lowey Dannenberg et
Oct 17, 2016 ... A. Schwarzenegger et al. v. M. Plata and R. Coleman, et al. J.D.B. v. State of ... at
Austin, et al. Boehringer Ingelheim Pharmaceuticals, Inc. v.
Jan 8, 2015 ... settled. 35 Eagle Creek Software Services,. Inc. v. Jones et al. (Ron. Sowers), 14-
cv-04925-ADM- .... 53 Gillette et al. v Boehringer. Ingelheim Pharmaceuticals Inc.
et al., 15-cv-03005-MJD-FLN .... 74 Coleman v. Mpls. Public.
rivaroxaban vs prior VKA) for ACTS burden and benefit scores were calculated ...
Boehringer Ingelheim Pharmaceuticals Inc., Daiichi Sankyo Company, and
Portola Pharmaceuticals. .... C. Coleman et al: Rivaroxaban and patient